Floatz logo

Exenatide

Prediabetes Syndrome

RenJi Hospitalprotein_peptidePhase 4 / ApprovedDormant
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
95/ 100

Competitive context

44 Active assets in the Prediabetes Syndrome cohort.

Asset / SponsorPhaseRating
Metformin
Yu Chen
Phase 4A
Liraglutide
Woman's
Phase 4BBB
Semaglutide
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 4BBB
Empagliflozin
The University of Texas Health Science Center at San Antonio
Phase 4BBB
Sitagliptin
Vanderbilt University Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

Exenatide is also rated in:

type 2 diabetes mellitusActive
BBB
Indicative · Phase 4
78 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BBB
Indicative · Phase 4
74 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →